GEN PROBE INC company info

CIK 820237
IRS Number 330044608
State of incorporation DE
Business address 10210 GENETIC CENTER DR.
Mail address 10210 GENETIC CENTER DR

Short summary

GEN PROBE INC is a California company, with head office located at 10210 Genetic Center Dr. San Diego, California 92121. The company achieved a record breaking net income in 2008 - 106.95 million USD. In 2011 the company owned a total of 1.10 billion USD worth of assets, including 492.26 million USD worth of current assets. 2010 was the year when the company amassed the most assets.

GEN PROBE INC Income Statement

Name [in Millions USD]20072008200920102011Trends
Research and development 101.10105.97111.10112.74
Amortization of Acquired Intangible Assets 4.148.8511.06
Operating Income (Loss) 145.40120.11137.85126.25
Interest expense 1.862.222.07
Investment Income, Interest and Dividend 16.8021.6011.778.70
Other Nonoperating Income (Expense) -1.33-0.06-0.18-0.24
Income Tax Expense (Benefit) 53.9148.0248.2743.03
Net income 106.9591.78106.9450.12

GEN PROBE INC Balance Sheet

Name [in Millions USD]20072008200920102011Trends
Cash and cash equivalents 75.96232.26174.92176.72138.77
Accounts Receivable, Net, Current 55.4252.7467.20
Inventories 57.7570.6781.33
Deferred income taxes 14.4713.178.71
Property, Plant and Equipment, Gross 384.96407.39
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 215.70227.12
Goodwill 121.94150.83140.39
Other Assets, Noncurrent 11.5711.91
Total assets 1,134.421,219.741,096.26
Current assets 615.04550.72492.26
Accounts payable 18.8511.3614.26
Total current liabilities 305.79303.20309.22
Deferred Revenue, Noncurrent 1.532.273.64
Deferred income taxes 21.9027.9619.28
Common Stock, Value, Issued
Retained Earnings (Accumulated Deficit) 572.24672.50699.46
Accumulated Other Comprehensive Income (Loss), Net of Tax -0.73-7.472.75


Name [in Millions USD]20072008200920102011Trends
Net income 106.9591.78106.9450.12
Depreciation 27.6026.8025.60
Depreciation and amortization 34.7240.3844.5346.57
Deferred Income Tax Expense (Benefit) -2.79-5.79-3.75-4.22
Inventories 5.37-2.321.1511.17
Accounts payable 4.383.50-6.27-2.70
Net Cash Provided by (Used in) Operating Activities 178.25145.03169.57181.25
Payments to Acquire Property, Plant, and Equipment 39.3532.3630.7241.66
Payments to Acquire Businesses, Net of Cash Acquired 183.7353
Payments to Acquire Intangible Assets 11.977.342.515.26
Net Cash Provided by (Used in) Investing Activities -139.89-198.38-114.4736.89
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures
Proceeds from Issuance of Common Stock 20.4710.9231.8349.93
Payments for Repurchase of Common Stock 74.97174.8599.94250
Net Cash Provided by (Used in) Financing Activities -53.5374.82-75.90-188.60
Cash and Cash Equivalents, Period Increase (Decrease) -15.8422.49-22.9327.33